European Archives - Page 899 of 1310 - European Medical Journal

Icosapent Ethyl for the Prevention of Cardiovascular Events

Based on genetic evidence, it is now known that triglyceride-rich lipoproteins lead to atherosclerosis and local inflammation, which can result in…

Why the Diagnosis of ATTR-Cardiomyopathy May Be a Challenge for Physicians

Cardiac amyloidosis is a rare but life-threatening group of disorders caused by the extracellular deposition of misfolded amyloid fibrils in cardiac tissue.

Analysing the Regulation of a Catecholamine-Dependent Altered cAMP Signalling in a Patient-Specific Induced Pluripotent Stem Cell Takotsubo-Model

The aim of the study was to prove the hypothesis of a phosphodiesterase (PDE)-dependent regulation of 3’,5’-cyclic adenosine monophosphate (cAMP)…

Cardiac Rehabilitation in Heart Failure: Looking Further Ahead

The authors present a brief overview on the current role of cardiac rehabilitation among HF patients in a contemporary setting and discuss some areas of…

Editor's Pick: Lipoprotein(a) and Calcific Aortic Valve Stenosis

In this review, the authors present and discuss the scientific and clinical evidence pertaining to the role of Lp(a) in calcific aortic valve stenosis.

Management of Atrial Fibrillation in Europe: Current Care Pathways and the Clinical Impact of Antiarrhythmic Drugs and Catheter Ablation

Atrial fibrillation (AF), the most common form of arrhythmia, increases the risk of heart failure, stroke, and death. Management of AF focusses on…

A Review of the Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic across Europe

Atrial fibrillation (AF), the most common form of arrhythmia, is characterised by an irregular and often fast heart rhythm resulting in uncoordinated…

Tricuspid Regurgitation: No Longer the ‘Forgotten’ Valve

In the last two decades, the interest in tricuspid valve (TV) treatment has increased;1,2 nevertheless, there is still a large percentage…

Chemokines: A Potential Therapeutic Target for the Stabilisation of Vulnerable Plaque

In the late 20th century, lipid lowering medications appeared to be the answer for coronary heart disease. However, despite reductions in mortality…

Circulating Cardiac Biomarkers in Heart Failure: A Critical Link to Biomarker-Guided Therapy

A contemporary conceptual framework that was proposed to distinguish between different chronic heart failure (HF) patients has highlighted varying…